Hartupee J, Mann DL (2017) Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol 14(1):30–38

CAS  PubMed  Google Scholar 

Packer M (1992) The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20(1):248–254

CAS  PubMed  Google Scholar 

Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B et al (2013) Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 34(11):835–843

PubMed  Google Scholar 

O’Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M (2005) Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 11(3):200–205

PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726

CAS  PubMed  Google Scholar 

Höög L, Strömberg A, Waldréus N, Nymark C (2025) Insights into clinical practice: a national survey on fluid intake management in heart failure. ESC Heart Fail

Mullens W, Damman K, Dhont S, Banerjee D, Bayes‐Genis A, Cannata A et al (2024) Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the heart failure association of the ESC. Eur J Heart Fail 26(4):730–41

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 145(18):e895–e1032

Ezekowitz JA, Colin-Ramirez E, Ross H, Escobedo J, Macdonald P, Troughton R et al (2022) Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. The Lancet 399(10333):1391–1400

CAS  Google Scholar 

Dauw J, Meekers E, Martens P, Deferm S, Dhont S, Marchal W et al (2024) Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: mechanistic insights into sodium handling. Eur J Heart Fail 26(3):616–624

CAS  PubMed  Google Scholar 

Herrmann JJ, Beckers-Wesche F, Baltussen LEHJM, Verdijk MHI, Bellersen L, Brunner-la Rocca HP et al (2022) Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: rationale and design of the randomized FRESH-UP study. J Card Fail 28(10):1522–30

Herrmann JJ, Brunner-La Rocca HP, Baltussen LEHJM, Beckers-Wesche F, Bekkers SCAM, Bellersen L et al (2025) Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial. Nat Med 31(6):2062–2068

Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G et al (2022) Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. The Lancet 400(10367):1938–1952

CAS  PubMed  Google Scholar 

Biegus J, Voors AA, Collins SP, Kosiborod MN, Teerlink JR, Angermann CE et al (2023) Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J 44(1):41–50

CAS  PubMed  Google Scholar 

Eng SH, Waldréus N, González B, Ehrlin J, Díaz V, Rivas C et al (2021) Thirst distress in outpatients with heart failure in a Mediterranean zone of Spain. ESC Heart Fail 8(4):2492–2501

PubMed  PubMed Central  Google Scholar 

van der Wal MHL, Jaarsma T, Jenneboer LC, Linssen GCM (2022) Thirst in stable heart failure patients; time to reconsider fluid restriction and prescribed diuretics. ESC Heart Fail 9(4):2181–2188

PubMed  PubMed Central  Google Scholar 

Holst M, Strömberg A, Lindholm M, Willenheimer R (2008) Liberal versus restricted fluid prescription in stabilised patients with chronic heart failure: result of a randomised cross-over study of the effects on health-related quality of life, physical capacity, thirst and morbidity. Scandinavian Cardiovascular Journal 42(5):316–322

PubMed  Google Scholar 

Aliti GB, Rabelo ER, Clausell N, Rohde LE, Biolo A, Beck-da-Silva L (2013) Aggressive fluid and sodium restriction in acute decompensated heart failure. JAMA Intern Med 173(12):1058

CAS  PubMed  Google Scholar 

Travers B, O’Loughlin C, Murphy NF, Ryder M, Conlon C, Ledwidge M et al (2007) Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability. J Card Fail 13(2):128–132

PubMed  Google Scholar 

Machado d’Almeida KS, Rabelo-Silva ER, Souza GC, Trojahn MM, Santin Barilli SL, Aliti G et al (2018) Aggressive fluid and sodium restriction in decompensated heart failure with preserved ejection fraction: results from a randomized clinical trial. Nutrition 54:111–117

PubMed  Google Scholar